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Background: We quantified the impact of lifestyle and dietary modifications on chronic kidney disease
(CKD) by estimating population-attributable fractions (PAFs).
Study Design: Observational cohort study.
Setting & Participants: Middle-aged adults with type 2 diabetes but without severe albuminuria from the
Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET; n5 6,916).
Factors: Modifiable lifestyle/dietary risk factors, such as physical activity, size of social network, alcohol
intake, tobacco use, diet, and intake of various food items.
Outcomes: The primary outcome was CKD, ascertained as moderate to severe albuminuria or$5% annual
decline in estimated glomerular filtration rate (eGFR) after 5.5 years. The competing risk for death was
considered. PAF was defined as the proportional reduction in CKD or mortality (within 5.5 years) that would
occur if exposure to a risk factor was changed to an optimal level.
Results: At baseline, median urinary albumin-creatinine ratio and eGFR were 6.6 (IQR, 2.9-25.0) mg/mmol and
71.5 (IQR,58.1-85.9)mL/min/1.73 m2, respectively.After 5.5years,704 (32.5%)participantsdevelopedalbuminuria,
1,194 (55.2%)hada$5%annual eGFRdecline, 267 (12.3%)hadboth, and1,022 (14.8%)haddied.Beingphysically
activeeverydayhasPAFsof5.1%(95%CI,0.5%-9.6%) forCKDand12.3%(95%CI,4.9%-19.1%) fordeath.Among
food items, increasing vegetable intakewould have the largest impact on population health. Considering diet, weight,
physical activity, tobacco use, and size of social network, exposure to less than optimum levels gives PAFs of 13.3%
(95% CI, 5.5%-20.9%) for CKD and 37.5% (95% CI, 27.8%-46.7%) for death. For the 17.8 million middle-aged
Americans with diabetes, improving 1 of these lifestyle behaviors to the optimal range could reduce the incidence
or progression of CKD after 5.5 years by 274,000 and the number of deaths within 5.5 years by 405,000.
Limitations: Ascertainment of changes in kidney measures does not precisely match the definitions for
incidence or progression of CKD.
Conclusions: Healthy lifestyle and diet are associated with less CKD and mortality and may have a sub-
stantial impact on population kidney health.
Am J Kidney Dis. 68(1):29-40.ª 2016 The Authors. Published by Elsevier Inc. on behalf of the National Kidney
Foundation, Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Dunkler et alfactor for cardiovascular disease and a burden to
health systems. An appealing approach may be to
encourage individuals to follow a healthy lifestyle
because comprehensive lifestyle interventions have
been shown to be medically effective.6,7
In 2 studies,8,9 we have evaluated associations of
modiﬁable lifestyle and dietary risk factors with the
incidence or progression of CKD and with mortality
for individuals with type 2 diabetes using data from
the Ongoing Telmisartan Alone and in Combination
With Ramipril Global Endpoint Trial (ONTAR-
GET)10-12: individuals with a healthier diet (modiﬁed
Alternate Healthy Eating Index, mAHEI),13,14 physi-
cally active individuals, individuals with a larger
social network (social network score),9 or individuals
with moderate alcohol intake exhibited lower risk for
CKD and mortality.
Here, we estimated population-attributable fractions
(PAFs),15 deﬁned as the proportion of CKD or mor-
tality cases that are attributable to a modiﬁable un-
healthy lifestyle or dietary risk factor. Thus, PAF
quantiﬁes the proportion of CKD cases or deaths that
could have been avoided by a healthier lifestyle. PAFs
can be computed for various lifestyle factors
by comparing the observed number of CKD cases or
deaths with the hypothetical numbers that would have
resulted if individuals had adhered to a healthier life-
style. Hence, beneﬁts of lifestyle modiﬁcation can be
compared quantitatively across different aspects of
lifestyle. Numerically, the PAF of a speciﬁc risk factor
combines into a single number the etiologic effect size
of the risk factor on the outcome, the prevalence of
unhealthy lifestyle (unfavorable exposure to the risk
factor), and an assumed reduction in that prevalence.
Hence, PAF analysis can reveal that a rare risk factor
with a strong effect may be responsible for only a few
CKD cases in a population, whereas a common risk
factor with a weak effect can cause many CKD cases.
The PAF measures the total effects of a risk factor
(direct and mediated through other factors). Therefore,
it can be used to assess the potential impact of pre-
ventive interventions on population health; for
example, for the United States, one can estimate how
many CKD cases in the approximately 17.8 million
individuals (in 2012) 45 years or older with diagnosed
diabetes are attributable to poor lifestyle behaviors.2
Although improvements in lifestyle might not sub-
stantially change CKD prognosis for one person, im-
provements in lifestyle due to a prevention program
can have noticeable consequences on a population
level. Because randomized trials of lifestyle in-
terventions for CKD are unlikely to be forthcoming,
analysis of thoroughly collected observational data
may give important clues to what extent CKD and
mortality may be attributable to lifestyle interventions
in a population of individuals with diabetes. Especially30in cancer research, many studies have quantiﬁed the
impact of modiﬁable lifestyle factors on cancer load,
and PAF has been noted as a useful epidemiologic
metric to develop effective prevention strategies
by concentrating on the most inﬂuential modiﬁable
factors.16-20
In this post hoc analysis, we quantifed PAFs for
immediately modiﬁable personal behaviors of life-
style and diet, including the mAHEI, body mass index
(BMI), physical activity, social network score, con-
sumption of alcohol, and tobacco use. Furthermore,
we evaluated intake of vegetables, fruits, proteins,
high-carbohydrate foods, and fried foods and urinary
potassium and sodium. These results may guide
public health recommendations for individuals with
diabetes with the aim to reduce the incidence or
progression of CKD and mortality and may help in
prioritizing strategies to improve lifestyle.
METHODS
Study Design and Population
ONTARGET (ClinicalTrials.gov study number NCT00153101)
randomly assigned 25,620 participants (aged $ 55 years) with
vascular disease or type 2 diabetes with end-organ damage to
receive telmisartan, ramipril, or both.10 The trial was approved
by the Research Ethics Board of Hamilton Health Sciences (#01-
252). Written informed consent was obtained from all participants.
We included all 6,916 participants with diabetes, no or moderate
albuminuria at baseline, and information for confounders and the
outcome (Fig S1, available as online supplementary material).
Selection of Modiﬁable Risk Factors
Risk factors for CKD were obtained once at baseline and
encompassed BMI, physical activity, social network score, alcohol
intake, tobacco use, and dietary patterns. Physical activity was
categorized into mainly sedentary, 1 or fewer times per week, 2 to
4 times per week, 5 to 6 times per week, or daily. The social
network score reﬂects how many people one regularly interacts
with. It was deﬁned as a weighted mean of 4 questions quantifying
the size of an individual’s social network (Item S2).9 Alcohol
intake was categorized according to World Health Organization
criteria into no, moderate, or heavy intake.21 Moderate intake was
deﬁned as 1 to 12 and 1 to 18 drinks per week for women and
men, respectively, with 1 drink equaling 1.5 ounces of hard liquor
or 1 glass of wine or beer. Food intake was recorded using a
qualitative food frequency questionnaire,8,14,22 measuring the
number of servings one regularly consumes for 20 food groups
during the past year. The questionnaire is applicable in multiple
countries despite regional differences.22 The mAHEI was used to
assess adherence to dietary guidelines.8,13,14 For each participant,
frequency of consumption of 8 food groups was scored as
described in Dehghan et al,14 but additionally, multivitamins were
added as in McCullough et al.13 Each food group contributes
between 0 and 10 points: higher mAHEI reﬂects intake of multi-
vitamins; higher intake of vegetables, fruits, nuts, or whole grains;
and lower intake of red and processed meats, fried foods, and
alcohol. Estimated 24-hour urinary sodium and potassium excre-
tion were estimated from a fasting morning urine sample.23,24
Study Outcome
Kidney function was measured twice during follow-up (2 and
5.5 years) and therefore the composite outcome was deﬁned as:Am J Kidney Dis. 2016;68(1):29-40
Table 1. Derivation of Study Outcome After 5.5 Years of
Follow-up
Study Outcome After 5.5 y No. (%) (n = 6,916)
Incidence or progression of CKD 2,165 (31.3)
Albuminuria 704 (32.5)
eGFR decline 1,194 (55.2)
Albuminuria & eGFR decline 267 (12.3)
Death 1,022 (14.8)
Alive without CKD 3,729 (53.9)
Note: Albuminuria, moderate or severe, was defined as pro-
gression of urinary albumin-creatinine ratio to.3.4 or.33.9 mg/
mmol, respectively, and an increase of at least 30% compared to
baseline. A clinically relevant eGFR decline was defined as
annual decline in eGFR$ 5%, need for emergent or long-term
dialysis during follow-up, and/or eGFR# 15 mL/min/1.73 m2 at
5.5 years. To be more precise, rather than onset and progres-
sion of CKD per se, we ascertained a decline in kidney measures
after 5.5 years.
Abbreviations: CKD, chronic kidney disease; eGFR, esti-
mated glomerular filtration rate.
Attributable Risk for CKD(1) alive without CKD after 5.5 years, (2) alive with CKD after
5.5 years, or (3) death within follow-up. Incidence or progression
of CKD was quantiﬁed as new moderate or severe albuminuria
and/or decline in estimated glomerular ﬁltration rate (eGFR).
Moderate or severe albuminuria was deﬁned as progression of
urinary albumin-creatinine ratio (UACR) to .3.4 or .33.9 mg/
mmol, respectively, and a $30% increase compared to baseline.
The 30%-increase rule prevented assumed random categorical
changes in 11 participants who started with a UACR slightly .3.4
or .33.9 mg/mmol. Clinically relevant eGFR decline was deﬁned
as an annual eGFR decline $ 5% (ie, measured as the slope over
eGFR measurements for each participant), need for dialysis during
follow-up, and/or eGFR # 15 mL/min/1.73 m2 at 5.5 years.
UACR was measured in 1 laboratory at baseline and 5 years, and
serum creatinine was measured at study sites at baseline and
5.5 years. eGFR was calculated using the CKD-EPI (CKD
Epidemiology Collaboration) equation.25
Statistical Analysis
Continuous variables are described as median and interquartile
range (IQR), categorical variables are summarized by frequency
and percentage. Complete case analysis was applied because only
111 (1.6%) participants had missing values at baseline. Diabetes
duration and UACR were log-transformed to avoid a dispropor-
tional inﬂuence of large values. Several multinomial logit regres-
sion models were ﬁtted to estimate the association of each
modiﬁable risk factor with CKD and death (single-factor models).
Possibly nonlinear outcome associations of continuous factors
were accounted for by using fractional polynomials with
P5 0.157,26 which approximately corresponds to selection by the
Akaike information criterion.27
All single-lifestyle-factor models were adjusted for predeﬁned
confounders including (at baseline) age, sex, diabetes duration,
ONTARGET randomization arm, albuminuria status, eGFR, and
d-UACR, which was deﬁned as log(3.4/UACRbaseline) or log(33.9/
UACRbaseline) for participants with no or moderate albuminuria.
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The d-UACR was modeled like this to account for the higher
probability of a stage change for individuals whose baseline
UACR was close to the stage-speciﬁc cutoff point and used the log
scale to avoid disproportional inﬂuence of large values. No rele-
vant correlation among confounders and between confounders and
risk factors was detected. Pairwise interactions between con-
founders and risk factors were separately tested controlling for a
false discovery rate of 5%.28 No statistically signiﬁcant and clin-
ically relevant interaction was found.
A multivariable dietary model, including consumption of
alcohol, vegetables, fruits and fruit juices, animal and plant pro-
teins, high-carbohydrate foods, and fried foods, and urinary
potassium and sodium excretion, adjusted for the same con-
founders, was ﬁtted. Because modiﬁcations of lifestyle and dietary
risk factors are often closely related and their effects on later
outcomes are hardly separable, we refrained from estimating a
comprehensive multivariable model. However, a healthy lifestyle
score based on 5 modiﬁable risk factors was devised. Each
component contributed 1 point to the healthy lifestyle score if a
participant had exposure status associated with the lowest risk for
CKD and mortality (mAHEI $ 28, BMI $ 23-#30 kg/m2, daily
physical activity, social network score $ 25, and never smoker),
0.5 point was contributed for exposure with intermediate risk, and
0 point, for the most unfavorable exposure (mAHEI , 21,
BMI , 23 or .30 kg/m2, physical activity #1 time per week,
social network score , 13, and current smoker). A multinomial
logit model with healthy lifestyle score adjusted for the con-
founders was estimated.
Although multinomial logit models can be used to quantify the
association of each risk factor with CKD and death, they can also
serve to estimate, for each participant, the predicted probabilitiesAm J Kidney Dis. 2016;68(1):29-40of CKD and death based on the participant’s confounder values
and risk-factor exposures. For each participant, we estimated the
probability of CKD and death if unfavorable exposure to risk
factors was changed to a more favorable one. The sum of these
individual probabilities is an estimate of the number of CKD cases
and deaths expected under this alternative scenario. Adjusted
PAFs follow as (casesobserved 2 casesexpected)/casesobserved.
15 Un-
adjusted PAFs were derived from univariate models. The bootstrap
percentile method (1,000 resamples) was applied to estimate 95%
conﬁdence intervals (CIs). A 2-sided P, 0.05 was considered
statistically signiﬁcant. R statistical software, version 3.0.0, was
used for analysis.29
RESULTS
Association of Modiﬁable Lifestyle Factors With CKD
and Death
After 5.5 years of the 6,916 individuals with type 2
diabetes and no or moderate albuminuria, 1,022
(14.8%) died and 2,165 (31.3%) had incidence or
progression of CKD (Table 1; Fig S1). At baseline,
median age was 66 (IQR, 61-71) years, participants
had diabetes for a median of 9 (IQR, 3-16) years and a
median eGFR of 72 (IQR, 58-86) mL/min/1.73 m2,
and 5,342 (77.2%) had no albuminuria (Tables 2 and
Table S1).
In confounder-adjusted single-lifestyle-factormodels,
we detected decreased risk for CKD among in-
dividuals with a healthier diet (P , 0.001) and those
who were physically active (P 5 0.002), had a larger
social network (P 5 0.02), or moderately consumed
alcohol (vs no alcohol, P 5 0.001). For mortality, re-
sults were similar, but the protective effect of physical
activitywasmore pronounced (P , 0.001) and current
and former tobacco use increased the risk for death
(P , 0.001). In the multivariable dietary model
adjusted for the same confounders, we found lower
risk for CKD in individuals with moderate alcohol31
Table 2. Characteristics of Study Population at Baseline
Characteristics at Baseline
All Individuals
(n = 6,916)
No. of Vegetables Servings per Week (n = 6,887)
<1 (n = 177) 1-<4 (n = 725) 4-<7 (n = 1,214) 7-<14 (n = 2,393) ≥14 (n = 2,378)
Sex
Female 2,209 (31.9) 47 (26.6) 223 (30.8) 357 (29.4) 767 (32.1) 807 (33.9)
Male 4,707 (68.1) 130 (73.4) 502 (69.2) 857 (70.6) 1,626 (67.9) 1,571 (66.1)
Age, y 66 [61-71] 67 [61-72] 66 [62-71] 66 [60-71] 66 [61-71] 65 [60.2-71]
Duration of diabetes, y 9 [3-16] 9 [3-18] 10 [4-16] 9 [3-15] 9 [3-16] 8 [3-16]
UACR, mg/mmol 6.6 [2.9-25.0] 6.5 [2.4-25.9] 7.4 [3-29.3] 7.3 [2.8-27.1] 6.9 [2.9-25.6] 6.0 [2.8-22.8]
eGFR, mL/min/1.73 m2 71.5 [58.1-85.9] 73 [58.5-86.8] 71.1 [57.5-84.1] 71.9 [58.6-84.5] 71.5 [58-87.3] 71.3 [58.3-85.8]
Albuminuria
No 5,342 (77.2) 139 (78.5) 547 (75.4) 926 (76.3) 1,840 (76.9) 1,868 (78.6)
Moderate 1,574 (22.8) 38 (21.5) 178 (24.6) 288 (23.7) 553 (23.1) 510 (21.4)
eGFR category
$60 4,663 (67.4) 125 (70.6) 495 (68.3) 809 (66.6) 1,615 (67.5) 1,603 (67.4)
30-59.9 2,159 (31.2) 49 (27.7) 219 (30.2) 393 (32.4) 737 (30.8) 748 (31.5)
15-29.9 91 (1.3) 2 (1.1) 10 (1.4) 12 (1.0) 40 (1.7) 27 (1.1)
,15 3 (0.1) 1 (0.6) 1 (0.1) 0 (0.0) 1 (0.0) 0 (0.0)
Kidney function & albuminuria
eGFR$ 60 & no 920 (13.3) 22 (12.4) 113 (15.6) 175 (14.4) 305 (12.8) 301 (12.7)
eGFR$ 60 & moderate 3,743 (54.1) 103 (58.2) 382 (52.7) 634 (52.2) 1,310 (54.7) 1,302 (54.7)
eGFR 30-59.9 & no 611 (8.9) 15 (8.4) 55 (8.0) 110 (9.1) 224 (9.4) 201 (8.5)
eGFR 30-59.9 & moderate 1,548 (22.4) 34 (19.2) 52 (7.2) 283 (23.4) 513 (21.4) 547 (23.0)
eGFR 15-29.9 & no 42 (0.6) 1 (0.6) 7 (1.0) 3 (0.2) 23 (1.0) 8 (0.3)
eGFR 15-29.9 & moderate 49 (0.7) 1 (0.6) 3 (0.4) 9 (0.7) 17 (0.7) 19 (0.8)
eGFR, 15 & no 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.0) 0 (0.0)
eGFR, 15 & moderate 2 (0.0) 1 (0.6) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0)
ONTARGET randomization
Ramipril 2,251 (32.6) 67 (37.9) 236 (32.6) 384 (31.6) 768 (32.1) 786 (33.1)
Telmisartan 2,304 (33.3) 62 (35.0) 240 (33.1) 401 (33.0) 778 (32.5) 813 (34.2)
Combination 2,361 (34.1) 48 (27.1) 249 (34.3) 429 (35.3) 847 (35.4) 779 (32.8)
Ethnicity
White 4,699 (67.9) 124 (70.1) 487 (67.2) 902 (74.3) 1,758 (73.5) 1,403 (59)
Asian 1,173 (17.0) 8 (4.5) 86 (11.9) 135 (11.1) 317 (13.2) 627 (26.4)
Native Latin 650 (9.4) 37 (20.9) 112 (15.4) 113 (9.3) 202 (8.4) 183 (7.7)
Others 394 (5.7) 8 (4.5) 40 (5.5) 64 (5.3) 116 (4.8) 165 (6.9)
Region
Europe 3,088 (44.6) 90 (50.8) 357 (49.2) 686 (56.5) 1,175 (49.1) 769 (32.3)
North & South America 2,247 (32.5) 76 (42.9) 270 (37.2) 356 (29.3) 773 (32.3) 756 (31.8)
Asia & Australia 1,341 (19.4) 9 (5.1) 83 (11.4) 132 (10.9) 365 (15.3) 752 (31.6)
Rest of world 240 (3.5) 2 (1.1) 15 (2.1) 40 (3.3) 80 (3.3) 101 (4.2)
Note: Values for categorical variables are given as frequency (percentage); for continuous variables, as median [interquartile range].
eGFRs expressed in mL/min/1.73 m2.
Abbreviations: eGFR, estimated glomerular filtration rate using the Chronic Kidney Disease Epidemiology Collaboration formula25;
ONTARGET, Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial; UACR, urinary albumin-creatinine
ratio.
Dunkler et alintake (vs no alcohol, P 5 0.003), higher urinary po-
tassium excretion (P 5 0.001), or higher intake of
vegetables (P 5 0.02) and animal (P 5 0.003) and
plant proteins (P 5 0.02). Rates of CKD and death for
lifestyle factors are given in Table 3, highlighting the
differences in risk.
We summarized adherence to 5 healthy behaviors in a
5-point healthy lifestyle score (Table 4). A very good
healthy lifestyle score . 3.5 was observed in 1,58932(23.2%) participants, whereas 819 (11.9%) had a
healthy lifestyle score # 1. Individuals with higher
scores had signiﬁcantly reduced risk forCKDanddeath.
Evaluation of Possible Lifestyle Intervention
Strategies
Based on these data, we calculated PAFs corre-
sponding to various scenarios of unfavorable lifestyle
exposures. If there is a causal relationship betweenAm J Kidney Dis. 2016;68(1):29-40
Table 3. Distribution of Modifiable Lifestyle and Dietary Risk
Factors of Study Population at Baseline
Characteristic No. (%)
Baseline No. (%),
by Outcome
CKD Death
Modifiable lifestyle characteristics
BMI (n 5 6,883)
15-,23 kg/m2a 493 (7.2) 156 (31.6) 91 (18.5)
23-,25 kg/m2 832 (12.1) 229 (27.5) 140 (16.8)
25-,30 kg/m2 2,873 (41.7) 889 (30.9) 428 (14.9)
30-,35 kg/m2 1,827 (26.5) 584 (32.0) 235 (12.9)
35-,50 kg/m2 858 (12.5) 298 (34.7) 122 (14.2)
Physical activity
(n 5 6,913)
Mainly sedentary 1,659 (24.0) 569 (34.3) 322 (19.4)
#13/wk 806 (11.7) 250 (31.0) 121 (15.0)
2-43/wk 1,583 (22.9) 498 (31.5) 208 (13.1)
5-63/wk 474 (6.9) 146 (30.8) 65 (13.7)
Daily 2,391 (34.6) 701 (29.3) 305 (12.8)
Social network score
(n 5 6,898)
0%-,8% 1,244 (18.0) 412 (33.1) 237 (19.1)
8%-,13% 1,219 (17.7) 382 (31.3) 178 (14.6)
13%-,25% 2,144 (31.1) 666 (31.1) 310 (14.5)
25%-100% 2,291 (33.2) 703 (30.7) 293 (12.8)
Alcohol intake
(n 5 6,914)b
None 4,678 (67.7) 1,541 (32.9) 718 (15.4)
Moderate 2,058 (29.8) 570 (27.7) 282 (13.7)
High 178 (2.6) 53 (29.8) 22 (12.4)
Tobacco use
(n 5 6,907)
Never 2,759 (39.9) 902 (32.7) 359 (13.0)
Former 755 (10.9) 213 (28.2) 144 (19.1)
Current 3,393 (49.1) 1,047 (30.9) 518 (15.3)
Modifiable dietary risk factors
mAHEI (n 5 6,916)
9-,21 2,271 (32.8) 766 (33.7) 423 (18.6)
21-,28 2,303 (33.3) 736 (32.0) 327 (14.2)
28-67 2,342 (33.9) 663 (28.3) 272 (11.6)
Est 24-h urinary
potassium
(n 5 6,903)
0.8-,1.5 g 421 (6.1) 149 (35.4) 58 (13.8)
1.5-,1.9 g 1,758 (25.5) 546 (31.1) 268 (15.2)
1.9-,2.4 g 2,528 (36.6) 802 (31.7) 388 (15.4)
2.4-5.0 g 2,196 (31.8) 663 (30.2) 308 (14.0)
Est 24-h urinary
sodium
(n 5 6,901)
0.6-,3.0 g 734 (10.6) 248 (33.8) 133 (18.1)
3.0-,4.5 g 2,042 (29.6) 610 (29.9) 323 (15.8)
4.5-,6.0 g 2,457 (35.6) 772 (31.4) 312 (12.7)
6.0-10.0 g 1,668 (24.2) 529 (31.7) 253 (15.2)
Fried foods: trans fat
(n 5 6,901)
No 3,657 (53.0) 1,149 (31.4) 536 (14.7)
Yes 3,244 (47.0) 1,009 (31.1) 484 (14.9)
High-carbohydrate
foods (n5 6,889)
0-,1 servings/wk 699 (10.1) 210 (30.0) 88 (12.6)
1-,4 servings/wk 1,252 (18.2) 397 (31.7) 177 (14.1)
Table 3 (Cont’d). Distribution of Modifiable Lifestyle and Dietary
Risk Factors of Study Population at Baseline
Characteristic No. (%)
Baseline No. (%),
by Outcome
CKD Death
4-,7 servings/wk 851 (12.4) 282 (33.1) 135 (15.9)
7-,14 servings/wk 1,652 (24.0) 493 (29.8) 247 (15.0)
14-49 servings/wk 2,435 (35.3) 773 (31.8) 371 (15.2)
Fruit and fruit juices
(n5 6,894)
0-,1 servings/wk 295 (4.3) 99 (33.6) 52 (17.6)
1-,4 servings/wk 1,047 (15.2) 351 (33.5) 184 (17.6)
4-,7 servings/wk 1,603 (23.3) 492 (30.7) 228 (14.2)
7-,14 servings/wk 2,436 (35.2) 771 (31.7) 347 (14.2)
14-28 servings/wk 1,513 (22.0) 443 (29.38) 208 (13.8)
Vegetables
(n5 6,887)
0-,1 servings/wk 177 (2.6) 66 (37.3) 33 (18.6)
1-,4 servings/wk 725 (10.5) 227 (31.3) 154 (21.2)
4-,7 servings/wk 1,214 (17.6) 393 (32.4) 180 (14.8)
7-,14 servings/wk 2,393 (34.8) 769 (32.1) 345 (14.4)
14-35 servings/wk 2,378 (34.53) 698 (29.4) 307 (12.9)
Leafy green
vegetables
(n5 6,894)
0-,1 servings/wk 853 (12.4) 295 (34.6) 161 (18.9)
1-,4 servings/wk 2,864 (41.5) 893 (31.2) 429 (15.0)
4-,7 servings/wk 218 (3.2) 75 (34.4) 25 (11.5)
7-,14 servings/wk 1,947 (28.2) 609 (31.3) 272 (14.0)
14 servings/wk 1,012 (14.7) 283 (28.0) 132 (13.0)
Animal protein
(n5 6,894)
0.00-,0.40 g/kg/d 2,669 (38.7) 890 (33.4) 403 (15.1)
0.40-,0.60 g/kg/d 2,033 (29.5) 622 (30.6) 303 (14.9)
0.60-2.45 g/kg/d 2,192 (31.8) 643 (29.3) 314 (14.3)
Plant protein
(n5 6,889)
0.00-,0.07 g/kg/d 2,352 (34.1) 748 (31.8) 362 (15.4)
0.07-,0.15 g/kg/d 2,565 (37.2) 806 (31.4) 395 (15.4)
0.15-0.65 g/kg/d 1,972 (28.6) 601 (30.5) 261 (13.2)
Total protein
(n5 6,887)
0.00-,0.47 g/kg/d 2,270 (33.0) 772 (34.0) 341 (15.0)
0.47-,0.66 g/kg/d 1,887 (27.4) 594 (31.5) 291 (15.4)
0.66-,0.85 g/kg/d 1,163 (16.9) 344 (29.6) 154 (13.2)
0.85-2.65 g/kg/d 1,567 (22.8) 444 (28.3) 232 (14.8)
Note: For descriptive purposes only, continuous risk factors
were categorized. The number of available observations and
frequencies and percentages of cases of incidence or progres-
sion of CKD and deaths in each category are given.
Abbreviations: BMI, body mass index; CKD, (incidence or
progression of) chronic kidney disease; Est, estimated; mAHEI,
modified Alternate Healthy Eating Index.
aOf the 493 (7.2%) individuals with such a BMI, 156 (31.6%) had
CKD after 5.5 years and 91 (18.5%) died within these 5.5 years.
bAlcohol was categorized by sex-specific World Health Orga-
nization guidelines. Moderate intake was defined as 1 to 12 and
1 to 18 drinks per week for women and men, respectively.
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Attributable Risk for CKDlifestyle factors and CKD and death, one can use these
PAFs to evaluate the impact of various possible life-
style interventions on the relative reduction in CKD33
Table 4. Healthy Lifestyle Score and Incidence or Progression of CKD and Death
HLS Score
HLS Pointsa Distribution, % %CKD
b ORCKD (95% CI) %Death
c ORDeath (95% CI)
0-1 11.9 35.0 1.00 (reference)d 19.0 1.00 (reference)d
1.5 12.6 34.2 0.88 (0.83 to 0.92) 18.2 0.76 (0.71 to 0.82)
2 16.8 31.2 0.82 (0.76 to 0.89) 15.3 0.67 (0.60 to 0.75)
2.5 18.9 29.6 0.76 (0.69 to 0.85) 15.1 0.59 (0.51 to 0.68)
3 16.6 32.0 0.72 (0.63 to 0.82) 14.8 0.51 (0.43 to 0.61)
.3.5 23.2 29.1 0.58 (0.47 to 0.72)e 9.8 0.34 (0.26 to 0.46)e
Outcomes
HLS Alternative Level
% of People
Who Must
Be Shifted
CKD Death
PAF, %
Excess Attributable
Cases, in 1,000 PAF, %
Excess Attributable
Cases, in 1,000
,1/ 1 4 0.09 (20.01 to 0.20) 5 0.59 (0.38 to 0.84) 15
,1.5/ 1.5 12 0.32 (0.00 to 0.66) 18 1.77 (1.16 to 2.47) 46
,2/ 2 25 0.85 (0.11 to 1.62) 47 4.06 (2.72 to 5.56) 105
,2.5/ 2.5 41 1.81 (0.41 to 3.28) 102 7.68 (5.24 to 10.33) 200
,3/ 3 60 3.30 (0.93 to 5.76) 186 12.64 (8.78 to 16.74) 328
,3.5/ 3.5 77 5.31 (1.66 to 8.93) 299 18.55 (13.13 to 24.16) 481
,5/ 5f 99 13.29 (5.54 to 20.86) 747 37.46 (27.77 to 46.67) 973
,X/ X11g 99 4.87 (1.78 to 7.91) 274 15.58 (11.21 to 20.02) 405
,X/ X12 99 9.29 (3.71 to 14.82) 522 27.67 (20.24 to 34.96) 718
Note: The HLS summarizes adherence to 5 healthy behaviors and ranges from 0 to 5 (optimal level). A multinomial logit model with
the HLS adjusted with (at baseline) age, sex, duration of diabetes, ONTARGET randomization arm, albuminuria status, eGFR, and
d-UACR, which was defined as log(3.4/UACRbaseline) or log(33.9/UACRbaseline) for patients with no or moderate albuminuria, was
estimated (n5 6,854). PAFs for CKD (after 5.5 years) and 5.5-year mortality, which quantify the proportional reductions of incidence or
progression of CKD and death that would occur if the exposure to a modifiable risk factor had been shifted to an alternative (ie, optimal)
level, are given with 95% CIs for different scenarios; for example, “,1.5/ 1.5” means that individuals with an HLS, 1.5 improve their
HLS to 1.5, whereas individuals with an HLS $ 1.5 do not change their HLS. “Excess attributable cases, in 1,000” were extrapolated
from the ONTARGET cohort to the approximately 17.8 million individuals older than 44 years with diagnosed diabetes in the United
States; assuming that this population is comparable to the ONTARGET population. Based on our results, approximately 5.6 million
cases of CKD (after 5.5 years) and 2.6 million deaths (within 5.5 years) can be expected in this population. Unadjusted PAFs and
excess attributable cases for the population of middle-aged individuals with diabetes in the European Union are given in Table S2.
Abbreviations: BMI, body mass index; CI, confidence interval; CKD, (incidence of progression of) chronic kidney disease; eGFR,
estimated glomerular filtration rate; HLS, healthy lifestyle score; mAHEI, modified Alternate Healthy Eating Index; ONTARGET,
Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial; OR, odds ratio; PAF, population-attributable
fraction; UACR, urinary albumin-creatinine ratio.
aOne point was awarded for being in the category with lowest risk (mAHEI$ 28, BMI of 23-#30 kg/m2, daily physical activity, social
network score $ 25, never smoker), 0.5 point for the category with intermediate risk, and 0 point for the category with the highest risk
(mAHEI, 21, BMI , 23 or .30 kg/m2, physical activity # 13/wk, social network score , 13, current smoker).
bPercentage of cases of incidence or progression of CKD in each category of the score.
cPercentage of deaths in each category of the score.
dReference category is HLS of 0.5.
eORs are given for HLS of 4.5.
fA very unrealistic scenario in which everyone is shifted to the category with the lowest risk in all 5 areas of lifestyle.
gA more realistic scenario in which everyone increases his or her score by 1, ie, 1 lifestyle behavior is improved to the optimal level.
(Individuals with an optimal score of 5 do not change and individuals with a score of 4.5 increase by only 0.5).
Dunkler et alcases and deaths, assuming full adherence to such in-
terventions (Table 5). If individuals with a suboptimal
diet (eg,mAHEI , 28) reached anmAHEI of 28, PAFs
are 2.4% (95%CI, 0.3%-4.6%) for CKD after 5.5 years
and 13.8% (95% CI, 9.8%-17.4%) for death within 5.5
years. If individuals with BMI, 23 or .30 kg/m2
achieved a BMI of 23 or 30 kg/m2, PAFs for CKD and
death are 1.5% (95% CI, 20.1% to 3.0%) and 1.7%
(95%CI,20.5% to 4.3%). If everyone were physically34active every day, PAFs are 5.1% (95%CI, 0.5%-9.6%)
for CKD and 12.3% (95% CI, 4.9%-19.1%) for death.
A social network of 25 or fewer people would reduce
the estimated fractions by 1.2% (95% CI, 20.9% to
3.4%) for CKD and 6.3% (95% CI, 3.0% to 9.7) for
death.
Among all dietary modiﬁcations, the largest impact
on CKD and death results from increasing vegetable
intake, especially leafy green vegetables. If everyoneAm J Kidney Dis. 2016;68(1):29-40
Table 5. PAFs of Modifiable Lifestyle and Dietary Risk Factors for Incidence or Progression of CKD and Death
Modifiable Risk Factors
and Alternative Levels % of People Shifted
CKD Death
PAF, %
Excess Attributable
Cases, in 1,000 PAF, %
Excess Attributable
Cases, in 1,000
mAHEI
,28/ 28 66 2.41a 135 13.77a 358
,21/ 21 33 0.52 29 3.90a 101
BMIb
,23/ 23 & .30/ 30 kg/m2 46 1.45 82 1.67 44
.30/ 30 kg/m2 39 1.52a 85 1.15 30
Physical activityc
0-6/ 73/wk 65 5.08a 286 12.29a 319
#1/ 2-43/wk & 2-6/ 73/wk 65 2.66 149 10.23a 266
#1-6/ 73/wkd 41 2.40 135 3.70 96
Social network score
,25/ 25 67 1.18 66 6.28a 163
,13/ 13 36 0.46 26 2.89a 75
Alcohol intakee
None, high/ moderate 70 8.77a 493 5.03 131
High/ moderate 3 0.17 9 20.15 24
Tobacco usef
Current/ formerg 49 20.98 255 4.76a 124
Former, current/ never 60 21.66 293 13.70a 356
Vegetables
,21/ 21 servings/wk 83 2.24 126 12.61a 327
,14/ 14 servings/wk 60 1.59 89 9.04a 235
,7/ 7 servings/wk 26 0.80 45 4.19a 109
,4/ 4 servings/wk 13 0.51 29 1.89a 49
X/ X12 servings/wk 100 0.89 50 4.10a 107
Leafy green vegetables
,7/ 7 servings/wk 57 2.38a 134 6.90a 179
,4/ 4 servings/wk 54 1.53 86 4.70a 122
,2/ 2 servings/wk 34 0.81 46 2.71a 70
X/ X12 servings/wk 100 1.72a 96 5.06a 131
Fruits and fruit juices
,21/ 21 servings/wk 84 3.50 197 11.27a 292
,14/ 14 servings/wk 58 2.39 134 7.79a 202
,7/ 7 servings/wk 24 1.03 58 3.34a 86
,4/ 4 servings/wk 19 0.55 31 1.60a 41
X/ X12 servings/wk 100 1.02 57 3.15a 82
Total proteinh
,0.85/ 0.85 g/kg/d 77 4.41a 248 3.22 84
,0.7/ 0.7 g/kg/d 65 2.64a 149 1.91 50
,0.66/ 0.66 g/kg/d 60 2.23a 126 1.61 41
Animal protein
,0.6/ 0.6 g/kg/d 68 2.70a 151 1.71 44
,0.4/ 0.4 g/kg/d 39 0.85a 47 0.53 14
Plant protein
,0.15/ 0.15 g/kg/d 71 1.94 109 3.08 80
,0.07/ 0.07 g/kg/d 34 0.41 23 0.66 17
High-carbohydrate foods
.4/ 4 servings/wk 72 0.25 14 1.31a 34
.7/ 7 servings/wk 59 0.11 6 0.62a 16
.14/ 14 servings/wk 35 0.03 1 0.15a 4
(Continued)
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Table 5 (Cont’d). PAFs of Modifiable Lifestyle and Dietary Risk Factors for Incidence or Progression of CKD and Death
Modifiable Risk Factors
and Alternative Levels % of People Shifted
CKD Death
PAF, %
Excess Attributable
Cases, in 1,000 PAF, %
Excess Attributable
Cases, in 1,000
Fried foods
Yes/ no 47 0.51 29 2.14 56
Est 24-h urinary potassium
,2.4/ 2.4 g 68 3.40a 191 0.80 20
,1.9/ 1.9 g 32 0.82a 46 0.18 4
Est 24-h urinary sodiumi
.1.5/ 1.5 g 99 26.12 2344 240.99 21,064
,3/ 3 & .6/ 6 g 35 20.06 24 3.55a 92
,3/ 3 g 11 0.12 6 1.55a 40
.6/ 6 g 24 20.17 210 1.93a 50
Note: For each lifestyle and dietary risk factor, a separate (adjusted) multinomial logit model was estimated and the impact on
population health, quantified by PAFs, was computed for several scenarios. The model was adjusted with (at baseline) age, sex,
duration of diabetes, ONTARGET randomization arms, albuminuria status, eGFR, and d-UACR, which was defined as log(3.4/
UACRbaseline) or log(33.9/UACRbaseline) for patients with no or moderate albuminuria. “Excess attributable cases, in 1,000” were
extrapolated from the ONTARGET cohort to the approximately 17.8 million individuals older than 44 years with diagnosed diabetes in
the United States. For a description of the interpretation of the PAF and excess attributable cases, refer to Table 4. Unadjusted PAFs,
95% confidence intervals for adjusted PAFs, and excess attributable cases for the population of middle-aged individuals with diabetes
in the European Union are given in Table S3.
Abbreviations: BMI, body mass index; CKD, (incidence or progression of) chronic kidney disease; Est, estimated; mAHEI, modified
Alternate Healthy Eating Index; ONTARGET, Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial;
PAF, population-attributable fraction.
aPAFs significant at a5 0.05.
bWorld Health Organization recommendations for a healthy BMI range from 18.5 to 25.0 kg/m2 for adults.46 However, these rec-
ommendations might be too restrictive for the elderly because it has been shown that for people older than 64 years, the risk for
mortality increases with BMI , 23 or . 30 kg/m2.47
cPhysical activity is categorized into being mainly sedentary and being physical active #13/wk, 2-43/wk, 5-63/wk, and daily
(73/wk).
dAssuming individuals who are mainly sedentary cannot change their physical activity due to health issues.
eAlcohol intake was categorized according to sex-specific World Health Organization guidelines. Moderate intake defined as 1 to 12
and 1 to 18 drinks per week for women and men, respectively.
fTobacco use is categorized into never, former, and current smoker.
gThe negative PAF for the competing risk for CKD is likely due to life years gained after cessation of smoking.
hFor healthy adults, the estimated average protein requirement is 0.66 g/kg/d and the recommended dietary allowance is 0.80.48
Campbell et al48 suggested that protein requirements for older people are not statistically different and estimated an adequate pro-
tein allowance to be 0.85 g/kg/d.
iDietary guidelines for Americans recommend a maximum sodium intake of 1.5 g/d for people older than 50 years.49 However,
O’Donnell et al showed that an estimated sodium intake between 3 and 6 g/d was associated with a lower risk for death and car-
diovascular events.50-53
Dunkler et alate 2 additional servings of leafy green vegetables per
week, PAFs are 1.7% (95% CI, 0.0%-3.6%) for CKD
and 5.1% (95% CI, 2.3%-7.9%) for death. Another
strategy could be to motivate individuals to consume
at least 3 servings of vegetables per day, which would
reduce the estimated fractions of CKD and death by
2.2% (95% CI, 20.8% to 5.4%) and 12.6% (95% CI,
8.3% to 17.1%). For CKD, a similar value could be
achieved by increasing the number of servings of
fruits and fruit juices to at least 2 per day (PAF, 2.4%;
95% CI, 20.2% to 5.0%). Low total protein intake
(,0.85 g/kg/d) yields PAFs of 4.4% (95% CI, 1.7%
to 7.2%) for CKD and 3.2% (95% CI, 21.2% to
7.3%) for death. Increasing minimum potassium
excretion to 2.4 g corresponds to PAF reductions of363.4% (95% CI, 1.2% to 5.6%) for CKD and 0.80%
(95% CI, 22.7% to 4.1%) for death.
Whereas PAFs derived from single lifestyle factor
models estimate the potential reduction in CKD or
death of 1 lifestyle intervention, PAFs from a multi-
variable model offer additional information of the
possible reduction of simultaneous lifestyle in-
terventions. The multivariable dietary model suggests
that although a reduction in alcohol intake would have
the largest impact on CKD, increasing vegetable
intake may have the largest impact on mortality
(Table 6). Changing all dietary factors to the assumed
optimal levels yields PAFs of 20.5% (95% CI, 12.3%-
27.4%) for CKD and 29.8% (95% CI, 19.5%-39.2%)
for death.Am J Kidney Dis. 2016;68(1):29-40
Table 6. Multivariable Dietary Model and PAF of Dietary Risk Factors for Incidence or Progression of CKD and Death
Modifiable Dietary Factors Alternative Levels
% of People
Shifted
CKD Death
PAF, %
Excess Attributable
Cases, in 1,000 PAF, %
Excess Attributable
Cases, in 1,000
Modify each risk factor separately
Alcohol intakea None, high/ moderate 70 8.09 454 4.89 127
Vegetables ,21/ 21 servings/wk 83 1.02 57 12.14 315
Fruits & fruit juices ,14/ 14 servings/wk 58 1.22 68 4.87 126
Animal protein ,0.6/ 0.6 g/kg/d 68 2.70 152 0.17 4
Plant protein ,0.15/ 0.15 g/kg/d 71 1.93 108 2.56 67
High-carbohydrate foods .7/ 7 servings/wk 59 0.46 26 2.38 62
Fried foods Yes/ no 47 0.95 53 0.98 25
Est 24-h urinary potassium ,2.4/ 2.4 g 68 3.71 209 0.26 7
Est 24-h urinary sodium ,3/ 3 & .6/ 6 g 35 0.10 6 3.54 92
Modify all risk factors simultaneously 100 20.48 1,147 29.81 775
Note: Adjusted PAFs of incidence or progression of CKD after 5.5 years and 5.5-year mortality of dietary food groups from the
multivariable model adjusted with (at baseline) age, sex, duration of diabetes, ONTARGET randomization arms, albuminuria status,
eGFR, and d-UACR, which was defined as log(3.4/UACRbaseline) or log(33.9/UACRbaseline) for patients with no or moderate albu-
minuria. “Excess attributable cases, in 1,000” were extrapolated from the ONTARGET cohort to the approximately 17.8 million in-
dividuals older than 44 years with diagnosed diabetes in the United States. For a description of the interpretation of the PAF and
excess attributable cases, refer to Table 4. PAFs are given for 2 scenarios; either only 1 food group is changed according to the
alternative level (and all other food groups remain constant) or all food groups are changed to their respective alternative levels
simultaneously. Unadjusted PAFs, 95% confidence intervals, and excess attributable cases for the population of middle-aged in-
dividuals with diabetes in the European Union for adjusted PAFs are given in Table S4.
Abbreviations: CKD, (incidence or progression of) chronic kidney disease; eGFR, estimated glomerular filtration rate; Est, estimated;
ONTARGET, Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial; PAF, population-attributable
fraction; UACR, urinary albumin-creatinine ratio.
aAlcohol intake is categorized according to sex-specific World Health Organization guidelines. Moderate intake was defined as 1 to
12 and 1 to 18 drinks per week for women and men, respectively.
Attributable Risk for CKDIf individuals improved their healthy lifestyle scores
to$3.5, reductions in estimated fractions for CKD and
death would be 5.3% (95% CI, 1.7%-8.9%) and 18.6%
(95% CI, 13.1%-24.2%; Table 4). Another strategy
could be that everyone with a suboptimal healthy
lifestyle score improves their score by 1 point (ie,
improving 1 suboptimal behavior to the optimal
range), which gives PAFs of 4.9% (95% CI, 1.8%-
7.9%) for CKD and 15.6% (95%CI, 11.2%-20.0%) for
death. Improving the healthy lifestyle score by 2 points
corresponds to PAFs of 9.3% (95% CI, 3.7%-14.8%)
for CKD and 27.7% (95%CI, 20.2%-35.0%) for death.
DISCUSSION
This large observational cohort study suggests that
exposure to unfavorable levels in diet, weight, physical
activity, social network, and tobacco use is attributable
for up to 13% of cases of CKD incidence or progres-
sion (after 5.5 years) and 38% of deaths (within 5.5
years) among individuals 55 years or older with dia-
betes. In the approximately 17.8 million middle-aged
individuals with diagnosed diabetes in the United
States, this would correspond to a potential reduction
of approximately 750,000 cases of CKD (after 5.5
years). It is not realistic that optimal exposure for these
aspects of lifestyle can be attained by all individuals.
However, our results concerning healthy lifestyleAm J Kidney Dis. 2016;68(1):29-40score, composed of 5 dimensions of lifestyle behavior,
suggest that if everyone improved just 1 behavior,
CKD could be reduced by 5%, and 5.5-year mortality,
by 16%. A very similar deﬁnition of healthy lifestyle in
the European Prospective Investigation into Cancer
and Nutrition (EPIC) study showed that individuals
with a generally healthy lifestyle had a 78% lower
overall risk for developing a chronic disease.30
A healthy diet has been shown to support the pre-
vention and management of diabetes.31 Adherence to
a high-quality diet as measured by the mAHEI was
strongly associated with reduced risk for diabetes.32
Our results suggest that such a diet can also reduce
CKD. The American Diabetes Association does not
recommend that people with diabetes and kidney
disease decrease their protein intake.33,34 Our analysis
shows that a minimum intake of 0.85 g/kg/d of protein
could reduce CKD by 4% and 5.5-year mortality by
3%. However, 77% of the ONTARGET population
would have to increase protein consumption to reach
this goal. A secondary analysis of the Look AHEAD
(Action for Health in Diabetes) trial showed that an
intensive lifestyle intervention resulting in weight loss
should be considered in reducing CKD in individuals
with diabetes.35 Similarly, our results show that if
everyone had a BMI of 23 to 30 kg/m2,w2% of both
CKD cases and 5.5-year mortality could be avoided.37
Dunkler et alDaily physical activity could reduce CKD and 5.5-
year mortality by 5% and 12%, respectively, under-
scoring the importance of public health efforts to
increase physical activity. Even increasing one’s so-
cial network, that is, the number of people one regu-
larly interacts with, could have a noticeable impact on
population health. In individuals with diabetes, a
larger social network also supports personal self-
management and physical and mental well-being.36
A meta-analysis for cancer mortality showed that so-
cial support might prolong life and that its effects are
clinically meaningful.37 The social network may
affect health behavior, and individuals with a larger
social network may have more reliable access to the
health care system. A biological explanation is that
low social support is associated with shorter telomere
length in older individuals.38 Another meta-analysis
for the general population discussed that the effect
of an adequate social network on survival is compa-
rable to cessation of tobacco use.39
Although PAF is a very useful epidemiologic
measure, it should be interpreted with care: the concept
of PAF presupposes a causal relationship between risk
factors and an outcome, which cannot be veriﬁed with
observational data. It is derived for a speciﬁc popula-
tion and should only be applied to comparable
populations with similar exposure frequencies:
ONTARGET comprised middle-aged individuals with
diabetes and high cardiovascular risk. All participants
received angiotensin-converting enzyme inhibitors/
angiotensin receptor blockers, and most were treated
according to guidelines with preventive cardiovascular
drugs and were at target blood pressures. Depending
on region-speciﬁc differences, for example, smoking
habits or vegetable intake, the impact on public health
may be different. The PAF does not incorporate
reversibility of exposures and risk latency (eg, smokers
can never reach the low-risk category never smokers).
Hence, a PAF resulting from shifting current smokers
to former smokers (without changing the status of
nonsmokers) will quantify the maximum attainable
short-term effects of an antismoking campaign. From a
public health perspective, the long-term effects of a
preventive strategy, trying to minimize the incidence
of smoking in younger people, will be considered by a
PAF in which all current and former smokers are
shifted to the nonsmoker category. However, risk la-
tency may sometimes be overestimated because life-
style modiﬁcations can have surprising short-term
effects. For example, in Italy shortly after the ban of
smoking in all indoor public places, a noticeable
reduction in hospital admissions for acute myocardial
infarction was detected.40 Ornish et al41,42 showed that
comprehensive lifestyle changes had a positive effect
on telomerase activity and telomere length after only 3
months. In multicausal diseases such as CKD, different38interventions might be applied for disease prevention,
leading to similar reductions in incidence. The speciﬁc
choice of interventions may be based on associated
costs or individual preferences. The PAF should be
regarded as the maximum attainable impact on disease
load because lifestyle interventions will not perma-
nently shift all individuals to the category with the
lowest risk. However, knowledge of potential revers-
ible risks and their impact can help prioritize inter-
vention programs and guide patient education. Dietary
interventions have an additional trade-off (ie,
increased vegetable intake while maintaining caloric
neutrality is linked with a decline in another food
group, which may affect PAF).
Measurement errors in self-reported variables are
inevitable, as in any observational study. However,
misclassiﬁcations are likely to be independent of the
outcome and should not induce systematic bias. We
assessed decline in kidney measures rather than inci-
dence and progression of CKD. Lifestyle factors and
laboratory values were measured only once at baseline.
However, self-initiated lifestyle changes are rare.
Strengths of this study include a large number of CKD
cases observed in more than 30,000 patient-years. We
controlled for potential confounders and the competing
risk for mortality. The food frequency questionnaire
and mAHEI have been used successfully.13,14,22 Rec-
ommendations with regard to food groups are epide-
miologically more meaningful than recommending
speciﬁc nutrients.43 Because intervention studies of the
effects of lifestyle and/or dietary modiﬁcations would
require a large sample size and considerable economic
resources and would most likely not include kidney
function as a primary outcome, a carefully conducted
observational study may at least provide some guide-
lines on the impact of lifestyle modiﬁcations.
One may argue that the PAFs of these modiﬁable
risk factors are often not very large. However, all
these lifestyle and dietary factors are also known risk
factors for other conditions such as cardiovascular
disease, affect diabetes management, and have a wide
range of well-known health beneﬁts.44,45 The PAF
quantiﬁes potential health gains through disease pre-
vention by reduction of known risks. It is a useful tool
for health communication and may raise public
awareness and awareness of individuals with diabetes
on improved health expectancy and decreased risk for
CKD and mortality by adopting a healthier lifestyle.
Lifestyle changes are not easy and not always
achievable, but they have been shown to be affordable
effective prevention strategies. In the 17.8 million
middle-aged individuals with diagnosed diabetes in
the United States, improving just 1 of 5 lifestyle be-
haviors to the optimal range could reduce CKD after
5.5 years by 274,000 and the number of deaths within
5.5 years by 405,000.Am J Kidney Dis. 2016;68(1):29-40
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Item S1: The ONTARGET Investigators.
Item S2: Assessment of modiﬁable lifestyle factors.
Note: The supplementary material accompanying this article
(http://dx.doi.org/10.1053/j.ajkd.2015.12.019) is available at
www.ajkd.org
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